Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

By sjmartinez • June 12, 2023

Ziyeh S, Wong L, Basho RK. Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer. Curr Oncol Rep. 2023 Jul;25(7):689-698. doi: 10.1007/s11912-023-01393-6. Epub 2023 Apr 1. PMID: 37004700.

Tags: AKT inhibition, CDK4/6 inhibition, CERANs, Endocrine therapy, Fellow, General Internal Medicine, Hematology/Oncology, HER2 negative breast cancer, Hormone receptor-positive breast cancer, Olive View DoM, PI3K inhibition, PIK3CA mutation, PROTACs, Publications, SARMs, SERCAs, SERDs, SERMs

Sarah M. Jensen, MD & Michael F. Ayoub, MD Appointed Associate Program Directors for the UCLA Internal Medicine Residency Program

We are pleased to announce the appointments of Sarah M. Jensen, MD and Michael F. Ayoub, MD as associate program directors (APDs) for the UCLA[...]

Expansion of State Medicaid Policies Related to Telehealth, 2018-2023: A National Legal Mapping Study

Leung LB, Nguyen VP, Thompson CM, Santos JJ, Brayton CE, Ettner SL, Escarce JJ, McCourt AD. Expansion of State Medicaid Policies Related to Telehealth, 2018-2023:[...]

An Evidence Map of Tai Chi and Qigong, 2014-2024: A Systematic Review

Mak SS, Allen JE, Begashaw MM, Beroes-Severin JM, Miake-Lye IM, Shekelle PG. An Evidence Map of Tai Chi and Qigong, 2014-2024: A Systematic Review. J[...]